Does PALBOCICLIB Cause Respiratory disorder? 112 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 112 reports of Respiratory disorder have been filed in association with PALBOCICLIB (Ibrance). This represents 0.1% of all adverse event reports for PALBOCICLIB.
112
Reports of Respiratory disorder with PALBOCICLIB
0.1%
of all PALBOCICLIB reports
16
Deaths
44
Hospitalizations
How Dangerous Is Respiratory disorder From PALBOCICLIB?
Of the 112 reports, 16 (14.3%) resulted in death, 44 (39.3%) required hospitalization.
Is Respiratory disorder Listed in the Official Label?
Yes, Respiratory disorder is listed as a known adverse reaction in the official FDA drug label for PALBOCICLIB.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Respiratory disorder?
ADALIMUMAB (1,685)
METHOTREXATE (1,335)
ETANERCEPT (1,271)
PREDNISONE (1,053)
ABATACEPT (1,001)
TOCILIZUMAB (1,000)
LEFLUNOMIDE (952)
CERTOLIZUMAB PEGOL (923)
GOLIMUMAB (880)
ACETAMINOPHEN (869)
Which PALBOCICLIB Alternatives Have Lower Respiratory disorder Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID